Trials / Completed
CompletedNCT02711163
Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula
Evaluation of the Hypoallergenicity of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow's Milk Protein Allergy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- United Pharmaceuticals · Industry
- Sex
- All
- Age
- 1 Month – 36 Months
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the hypoallergenicity of a new thickened extensively hydrolyzed formula, in infants with confirmed cow's milk protein allergy assessed through a double blind placebo controlled food challenge, followed by a 3-month open feeding period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Extensively Hydrolyzed formula | |
| DIETARY_SUPPLEMENT | Amino acid formula |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-08-31
- Completion
- 2017-11-29
- First posted
- 2016-03-17
- Last updated
- 2018-05-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02711163. Inclusion in this directory is not an endorsement.